Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Elevar Therapeutics
Biotech
Elevar offers $500M biobucks for Relay's rare cancer asset
Relay has signed a deal worth up to $500 million biobucks that gives Elevar rights to an oral small molecule in solid tumors.
Gabrielle Masson
Dec 3, 2024 3:04pm
J&J's medtech chief out the door—Chutes & Ladders
Oct 27, 2023 9:30am
FDA shores up executive team with 2 hires—Chutes & Ladders
Jul 1, 2022 9:30am
Adding Elevar's EGFR drug to Iressa boosts lung cancer survival
Sep 21, 2020 8:40am
